Remission of rheumatoid arthritis (RA) strongly predicts a reduced risk of (sub)clinical atherosclerosis. Among cardiovascular risk factors, non-insulin-dependent diabetes mellitus (NIDDM) was significantly linked to (sub)clinical atherosclerosis in RA patients. These were the main findings of a 3-year observational study presented at EULAR 2019 .
Cardiovascular disease in patients with RA is known to be higher than what has been observed in the general population. Dr Pierro Ruscitti et al. (University of L’Aquila, Italy) evaluated the occurrence and the predictive factors of (sub)clinical atherosclerosis in 797 RA patients from the GIRRCS trial . Main outcomes were subclinical (carotid and/or peripheral atherosclerotic lesions detected by ultrasound imaging) and clinical atherosclerosis (myocardial infarction and/or congestive heart failure and/or cerebrovascular accidents). Both RA-related and traditional cardiovascular risk factors were assessed.<...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Isradipine does not slow progression of disability in early Parkinson Next Article
“We must shift our focus to the earlier stages of Alzheimer’s” »
Table of Contents: EULAR 2018
Psoriasis and Psoriatic Arthritis
Osteoporosis and Osteoarthritis
Systemic Sclerosis and Systemic Lupus Erythematosus
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.